JPRN-jRCT2053220055
Recruiting
Phase 1
Clinical trial of human (allogeneic) iPS cell-derived cardiomyocytes sheet for ischemic cardiomyopathy (Follow-up trial)
Miyagawa Shigeru0 sites10 target enrollmentJune 22, 2022
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Ischemic cardiomyopathy
- Sponsor
- Miyagawa Shigeru
- Enrollment
- 10
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\) Patients who have undergone iPS cell derived\-cardiomyocyte sheet (Clinical trial identification code:IPSOC\-1\) transplantation
- •2\) Patients who can obtain concent to participate in this trial
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 1
Clinical trial of human (allogeneic) iPS cell-derived cardiomyocytes sheet for dilated cardiomyopathyDilated cardiomyopathyD002311JPRN-jRCT2053230136Miyagawa Shigeru4
Active, not recruiting
Phase 1
Clinical trial of human (allogeneic) iPS cell-derived cardiomyocytes sheet for ischemic cardiomyopathyJPRN-jRCT2053190081Miyagawa Shigeru10
Recruiting
Not Applicable
Establishment of human iPS cells differentiation from TOFtetralogy of fallotJPRN-UMIN000031786Saitama medical university International medical Center20
Unknown
Phase 1
Clinical Trial of Human (Allogeneic) iPS Cell-derived Cardiomyocytes Sheet for Ischemic CardiomyopathyMyocardial IschemiaNCT04696328Osaka University10
Unknown
Phase 1
Autologous iPSC-Derived Dopamine Neuron Transplantation for Parkinson's DiseaseParkinson DiseaseNCT06422208Penelope J. Hallett, Ph.D.6